AKT1 and fatty liver disease: It also binds to IL-1 receptors in the liver, contributing to hepatic steatosis and inhibition of hepatic insulin action.[28] IL-6 and TNF-α induce insulin resistance by interfering with insulin receptor substrate-1, a key protein in the pathway activating PKB/Akt.[30,31]